| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 10,353 shares
@ $0
Granted 6,335 shares
@ $0 |
|
| 08/18/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 117 shares
@ $0
Sold 41 shares
@ $7.89, valued at
$323.5 |
|
| 08/15/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,045 shares
@ $0
Sold 1,760 shares
@ $7.89, valued at
$13.9k
|
|
| 08/15/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,332 shares
@ $0 |
|
| 08/14/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,466 shares
@ $0 |
|
| 08/14/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 130 shares
@ $0
Sold 44 shares
@ $8.1, valued at
$356.4 |
|
| 08/14/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,451 shares
@ $0
Sold 1,850 shares
@ $8.1, valued at
$15k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,599 shares
@ $0 |
|
| 08/11/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,855 shares
@ $0
Sold 2,106 shares
@ $8.08, valued at
$17k
|
|
| 08/11/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 141 shares
@ $0
Sold 50 shares
@ $8.08, valued at
$404 |
|
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 5,259 shares
@ $0
Sold 2,317 shares
@ $8.32, valued at
$19.3k
|
|
| 08/10/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 153 shares
@ $0
Sold 55 shares
@ $8.32, valued at
$457.6 |
|
| 08/10/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,733 shares
@ $0 |
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results|
Docs:
|
"PROPRIETARY AND CONFIDENTIAL ©2023 ENFUSION. ALL RIGHTS RESERVED. Disclaimer 2 Forward-Looking Statements Statements we make in this presentation may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 , including expectations regarding future financial performance. These forward-looking statements are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “could,” “will,”..." |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
4
| Hammoud Tarek (10% Owner) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 1,000,000 shares
@ $10.7, valued at
$10.7M
|
|
| 06/28/2023 |
4
| Somers Deirdre (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| Spellacy Michael (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| Hauser Jan (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| DeRose Kathleen (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
|